Name | SX-517 |
---|---|
Synonyms |
Boronic acid, B-[2-[[[5-[[(4-fluorophenyl)amino]carbonyl]-2-pyridinyl]thio]methyl]phenyl]-
{2-[({5-[(4-Fluorophenyl)carbamoyl]-2-pyridinyl}sulfanyl)methyl]phenyl}boronic acid SX-517 |
Description | A potent, specific, noncompetitive dual CXCR1 and CXCR2 antagonist with IC50 of 38 nM (vs. CXCL1) and 36 nM (vs. CXCL8), respectively; inhibits CXCL1-induced Ca(2+) flux in human PMNs but has no effect on the Ca(2+) flux induced by C5a, fMLF, or PAF; antagonizes CXCL8-induced [(35)S]GTPγS binding (IC50=60 nM) and ERK1/2 phosphorylation in recombinant HEK293 cells expressed CXCR2; significantly inhibits inflammation in an in vivo murine model (0.2 mg/kg iv). |
---|---|
References | References 1. Maeda DY, et al. J Med Chem. 2014 Oct 23;57(20):8378-97. 2. Schuler AD, et al.Bioorg Med Chem Lett. 2015 Sep 15;25(18):3793-7. View Related Products by Target Chemokine Receptor (CCR and CXCR) |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C19H16BFN2O3S |
Molecular Weight | 382.216 |
Exact Mass | 382.095886 |
LogP | 3.98 |
Index of Refraction | 1.663 |